Voltar
Artigo Revisado por pares
BIBTEX RIS

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

2003; Springer Science+Business Media; Volume: 52; Issue: 9 Linguagem: Inglês

10.1007/s00262-003-0396-5

ISSN

1432-0851

Autores

David R. Colnot, Jan C. Roos, Remco de Bree, Abraham J. Wilhelm, J. Alain Kummer, Gertraud Hanft, Karl-Heinz Heider, G. Stehle, Gordon B. Snow, Guus A.M.S. van Dongen,

Tópico(s)

Peptidase Inhibition and Analysis

Referência(s)